×
0 -0.010183299389002 -0.0264765784114053 -0.0427698574338085 -0.195112016293279 -0.169042769857434 -0.179226069246436 -0.169042769857434
Stockreport

BioScrip Reports Third Quarter 2017 Financial Results

BIOSCRIP (BIOS)  More Company Research Source: GlobeNewswire
Last bioscrip earnings: 5/10 08:30 am Check Earnings Report
US:NASDAQ Investor Relations: bioscrip.com/investors
PDF – Net revenue of $198.7 million, including core product mix of 75.0%, compared to 65.8% in the prior year– Net revenue and adjusted EBITDA reduced $10.0 million and $3.0 million, respectively, due to sales disruption from Hurricane Irma, Hurricane Harvey, and completion of the UnitedHealthcare contract transition– Net loss from continuing operations of $12.4 million, compared to $11.1 million in the prior year– Adjusted EBITDA of $13.0 million, more than three times the prior year, driven by a 590 basis point improvement in gross profit margin and a $4.8 million reduction in operating expenses– Operating cash use of $0.3 million, reflecting $15.8 million of interest, including $8.9 million of bi-annual bond interest payments, and $19.6 million of operational and working capital improvements over the prior year– Discontinued operations cash use of $5.6 million, inclusive of settlement payment accrued in the fourth quarter of 2016– Liquidity of $43.0 million, including $33.0 million of [Read more]

IMPACT SNAPSHOT EVENT TIME: BIOS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS